PCNA and breast carcinoma: Consistent with our finding, previous studies showed that the addition of exogenous cyclin EL increases the formation of cyclin EL/CDK2 complex correlating to the increased activity and phosphorylation of CDK2 in human lung fibroblasts [35] and breast cancer cells [84].